Research Article
Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma
Table 3
Expression of insulin receptor substrate 1 (IRS-1) in human HCC.
| Tissues/protein | IRS-1 expression | Negative | Weak | Moderate | Strong |
| Tissues of detection | | | | | HCC, (%) | 59 (59.0) | 15 (15.0) | 18 (18.0) | 8 (8.0) | PCT, (%) | 83 (83.0) | 11 (11.0) | 6 (6.0) | 0 (0.0) | LC, (%) | 17 (85.0) | 2 (10.0) | 1 (5.0) | 0 (0.0) | CHT, (%) | 18 (90.0) | 2 (10.0) | 0 (0.0) | 0 (0.0) | value | | | | | HCC Vs. PCT | <0.001 | 0.400 | 0.009 | — | HCC Vs. LC | 0.028 | 0.815 | 0.263 | — | HCC Vs. CHT | 0.008 | 0.815 | — | — | PCT Vs. LC | 1.000 | 1.000 | 1.000 | — | PCT Vs. CHT | 0.655 | 1.000 | — | — | LC Vs. CHT | 1.000 | 1.000 | — | — |
|
|
CHT: chronic hepatitis tissues; HCC: hepatocellular carcinoma; LC: liver cirrhosis; PCT: paracancerous tissues, , . |